+1 518-300-1218
Life Science

Next Generation Sequencing (NGS) Market Size, Growth & Outlook

Next Generation Sequencing (NGS) Market Size, Growth & Outlook
REPORT ID: FMI-0032 || VIEW: 106

Next Generation Sequencing (NGS) Market by Product (Consumables, Platforms, and Services) Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, and Other Technologies), and End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, and Other End User): Global Opportunity Analysis and Industry Forecast, 2019–2026

  • Report description
  • Table of Content

The global next generation sequencing market size was valued at $4,533 million in 2018, and is estimated to reach $18,565 million by 2026, growing at a CAGR of 19.2% from 2019 to 2026.


Next generation sequencing (NGS) is a novel procedure for sequencing genomes at low costs and high speed with improved efficiency. NGS also known as deep sequencing and parallel sequencing is a technology that has revolutionized molecular biology and genomics research. It is a high throughput, non-Sanger based sequencing method. Next generation sequencing has made sequencing of genomes very rapid and cost-effective. Through this method, billions of DNA strands can be sequenced efficiently. Next generation sequencing has made it possible to conveniently sequence whole genomes, and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. Next generation sequencing can be utilized through varied interventions such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.


Technological advancements in sequencing platforms, surge in applications of next generation sequencing, and increase in genome mapping programs drive the growth of the global next generation sequencing market. In addition, rise in awareness pertaining to next generation sequencing and increase in investment in research, development, and innovation supplement the market growth. However, lack of skilled professionals, ethical & legal limitation related to next generation sequencing, and standardization concerns in sequencing procedures impede the market growth. Furthermore, use of cloud computing as a potential data management service and untapped emerging economies offer lucrative opportunities for the market players.


The next generation sequencing market is segmented based on product, application, technology, end user, and region. Based on product, the market is divided into consumables, platforms, and services. The consumables product segment is further bifurcated as sample preparation consumables and other consumables. The sample preparation consumables are further segmented into DNA fragmentation, end repair, A-Tailing & size selection, library preparation & target enrichment, and quality control. The platform NGS product segment is classified into HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II & Sequel System, and other sequencing platforms. The services segment is divided into sequencing services and data management services. The sequencing services is further divided into RNA Sequencing, Whole Exome Sequencing, Whole Genome Sequencing, Targeted Sequencing, Chip Sequencing, De Novo Sequencing, and Methyl Sequencing. The data management services further divided into NGS data analysis services, NGS data analysis software & workbenches, and NGS storage, management & cloud computing solutions. Based on application, the market is divided into diagnostics, biomarkers and cancer, reproductive health, personalized medicine, agriculture and animal research, other applications. By Technology, market is segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, and other technologies. Depends on end user, market is categorized into academic & clinical research centers, pharmaceutical & biotechnology companies, hospitals & clinics, and other end user. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.


Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the next generation sequencing market in 2015, and is expected to retain its dominance throughout the forecast period. This is primarily attributed to higher buying power, availability, and applications that favor the utilization of NGS in this region. There is also an increase in agreements and collaborations between different market players and health centers to promote and utilize NGS in this region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in R&D facilities, available disposable income, and rapidly developing economic conditions.


Product development is the key strategy adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global next generation sequencing market.


• The study provides an in-depth analysis of the global next generation sequencing market along with the current trends and future estimations to elucidate the imminent investment pockets.
• The report presents quantitative analysis of the market for the period of 2014–2022 to enable stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the market based on product type assists in understanding the trends in the industry.
• Key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry



• By Product 

o Consumables
 Sample Preparation Consumables
• DNA Fragmentation, End Repair, A-Tailing and Size Selection
• Library Preparation & Target Enrichment
• Quality Control
 Other Consumables
o Platforms
 HiSeq
 MiSeq
 Ion Torrent
 Pacbio Rs II and Sequel System
 Other Sequencing Platforms

o Services

 Sequencing Services
• RNA Sequencing
• Whole Exome Sequencing
• Whole Genome Sequencing
• Targeted Sequencing
• Chip Sequencing
• De Novo Sequencing
• Methyl Sequencing

 Data Management Services

• NGS Data Analysis Services
• NGS Data Analysis Software & Workbenches
• NGS Storage, Management and Cloud Computing Solutions


• By Application

o Diagnostics
o Biomarkers and Cancer
o Reproductive Health
o Personalized Medicine
o Agriculture and Animal Research
o Other Applications


• By Technology

o Sequencing by Synthesis
o Ion Semiconductor Sequencing
o Sequencing by Ligation
o Pyrosequencing
o Single Molecule Real Time Sequencing
o Other Technologies


• By End User 

o Academic and Clinical Research Centers
o Pharmaceutical and Biotechnology Companies
o Hospitals and Clinics
o Other End User


• By Region

o North America
 U.S.
 Canada
 Mexico
o Europe
 Germany
 France
 UK
 Italy
 Spain
 Rest of Europe
o Asia-Pacific
 Japan
 China
 Australia
 India
 South Korea
 Taiwan
 Rest of Asia-Pacific
 Brazil
 Turkey
 Saudi Arabia
 South Africa
 Rest of LAMEA



• Illumina, Inc. 
• Thermo Fisher Scientific, Inc.
• Pacific Biosciences of California, Inc.
• Beijing Genomics Institute
• Qiagen N.V. 
• 454 Life Sciences Corporation (Roche Holding AG)
• Agilent Technologies, Inc.
• Perkinelmer, Inc.
• Genomatix GmbH 
• PierianDx

Other players in the value chain include (profiles not included in the report)

• Eurofins Scientific
• Gatc Biotech AG
• Macrogen, Inc.
• Oxford Nanopore Technologies, Ltd.
• Bio-Rad Laboratories, Inc.
• Biomatters Ltd.
• Partek Inc.
• New England Biolabs, Inc. 
• Myriad Genetics, Inc.


1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Key market segments
1.4.    Research methodology

1.4.1.    Primary research
1.4.2.    Secondary research
1.4.3.    Analyst tools and models


2.1.    CXO perspective
2.2.    Key findings

2.2.1.    Top impacting factors
2.2.2.    Top investment pockets


3.1.    Market definition and scope
3.2.    Parent Market Overview
3.3.    Key Forces Shaping Next generation sequencing Market

3.3.1.    Moderate bargaining power of suppliers
3.3.2.    Low threat of new entrants
3.3.3.    Low threat of substitutes
3.3.4.    Moderate intensity of rivalry
3.3.5.    High bargaining power of buyers

3.4.    Pricing Analysis

3.4.1.    Pricing Analysis, By Region, 2018 & 2026

3.5.    Market Evolution
3.6.    Value Chain Analysis
3.7.    Impact of Government Regulations on Global Next Generation Sequencing Market
3.8.    Patent Analysis (2016-2018)

3.8.1.    Patent Analysis, by Year
3.8.2.    By Country
3.8.3.    By Applicant

3.9.    Case Studies

3.9.1.    Case Study 01

3.10.    Market dynamics

3.10.1.    Drivers    Technological advancements in NGS    Surge in applications of NGS    Increase in partnerships and collaborations    Increase in genome mapping programs

3.10.2.    Restraints    Standardization concerns over NGS based diagnostics    Lack of skilled professionals    Ethical and legal limitations

3.10.3.    Opportunities    Lucrative opportunities in emerging markets    Cloud computing: potential data management service


4.1.    Overview
4.2.    Market size and forecast
4.3.    Consumables

4.3.1.    Key market trends, growth factors and opportunities
4.3.2.    Market size and forecast, by type    Sample preparation consumables    Market size and forecast, by type    DNA Fragmentation, End Repair, A-Tailing and Size Selection    Market size and forecast    Library preparation & target enrichment    Market size and forecast    Quality Control    Market size and forecast    Other Consumables    Market size and forecast

4.3.3.    Market size and forecast, by region
4.3.4.    Market analysis by country

4.4.    Platforms

4.4.1.    Key market trends, growth factors, and opportunities
4.4.2.    Market size and forecast, by type    HiSeq series    Market size and forecast    MiSeq series    Market size and forecast    ION Torrent    Market size and forecast    SOLiD    Market size and forecast    Pacbio Rs II and Sequel system    Market size and forecast    Other Sequencing Platforms    Market size and forecast

4.4.3.    Market size and forecast, by region
4.4.4.    Market analysis by country

4.5.    Services

4.5.1.    Key market trends, growth factors and opportunities
4.5.2.    Market size and forecast, by type    Sequencing Services    Market size and forecast, by type    RNA Sequencing    Market size and forecast    Whole exome sequencing    Market size and forecast    Whole genome sequencing    Market size and forecast    Targeted sequencing    Market size and forecast    Chip sequencing    Market size and forecast    De Novo sequencing    Market size and forecast    Methyl sequencing    Market size and forecast    Data management services    Market size and forecast, by type    NGS Data Analysis Services    Market size and forecast    NGS data analysis software & workbenches    Market size and forecast    NGS storage, management, and cloud computing solutions    Market size and forecast

4.5.3.    Market size and forecast, by region
4.5.4.    Market analysis by country


5.1.    Overview
5.2.    Market size and forecast
5.3.    Biomarkers and Cancer

5.3.1.    Market size and forecast, by region
5.3.2.    Market analysis by country

5.4.    Diagnostics

5.4.1.    Market size and forecast, by region
5.4.2.    Market analysis by country

5.5.    Reproductive Health

5.5.1.    Market size and forecast, by region
5.5.2.    Market analysis by country

5.6.    Personalized Medicine

5.6.1.    Market size and forecast, by region
5.6.2.    Market analysis by country

5.7.    Agriculture and Animal Research

5.7.1.    Market size and forecast, by region
5.7.2.    Market analysis by country

5.8.    Other Applications

5.8.1.    Market size and forecast, by region
5.8.2.    Market analysis by country


6.1.    Overview
6.2.    Market size and forecast
6.3.    Sequencing by Synthesis (SBS)

6.3.1.    Market size and forecast, by region
6.3.2.    Market analysis by country

6.4.    Ion Semiconductor Sequencing (IOS)

6.4.1.    Market size and forecast, by region
6.4.2.    Market analysis by country

6.5.    Sequencing by Ligation (SBL)

6.5.1.    Market size and forecast, by region
6.5.2.    Market analysis by country

6.6.    Pyrosequencing

6.6.1.    Market size and forecast, by region
6.6.2.    Market analysis by country

6.7.    Single-Molecule-Real-Time Sequencing (SMRT)

6.7.1.    Market size and forecast, by region
6.7.2.    Market analysis by country

6.8.    Other Technologies

6.8.1.    Market size and forecast, by region

Still have a doubt?

Enquire Before Buying

Select Licence Type

Avail customized purchase options

Request Customization